Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CNST - Constellation Pharma: CPI-0610 Is Well-Differentiated In The Myelofibrosis Treatment Development Pipeline

CNST - Constellation Pharma: CPI-0610 Is Well-Differentiated In The Myelofibrosis Treatment Development Pipeline

Constellation Pharmaceuticals Inc.
  • CNST's CPI-0610 has excellent Phase 2 data in MF.
  • Its SVR35 and TSS50 data compares favourably with other drugs in development and with Jakafi.
  • Current low prices make it a speculative bet.

For further details see:

Constellation Pharma: CPI-0610 Is Well-Differentiated In The Myelofibrosis Treatment Development Pipeline
Stock Information
Company Name: Constellation Pharmaceuticals Inc.
Stock Symbol: CNST
Market: NASDAQ
Website: constellationpharma.com
Menu
CNST CNST Quote CNST Short CNST News CNST Articles CNST Message Board
Get CNST Alerts

News, Short Squeeze, Breakout and More Instantly...